Skip to content
ppharmaranks
Menu
Class IIOngoing

3% Polocaine DENTAL recall

FDA recall D-0230-2026 · initiated Oct 31, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Dec 24, 2025How we research

Novocol Pharmaceutical of Canada, Inc. recalled 3% Polocaine DENTAL in Oct 2025 — an FDA Class II recall (D-0230-2026) because Defective container: cracked/broken cartridges.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Defective container: cracked/broken cartridges

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot: D05159C, expires: 07-31-2027

Quantity recalled: 5,825

Details

Product
3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16.
Recalling company
Novocol Pharmaceutical of Canada, Inc.
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S.A. Nationwide
Initiated
Oct 31, 2025
FDA report date
Dec 24, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was 3% Polocaine DENTAL recalled?
Novocol Pharmaceutical of Canada, Inc. recalled 3% Polocaine DENTAL in Oct 2025 — an FDA Class II recall (D-0230-2026) because Defective container: cracked/broken cartridges. May cause temporary or medically reversible harm; low probability of serious harm.
Why was 3% Polocaine DENTAL recalled?
Per the FDA enforcement record, the reason for recall D-0230-2026 was: Defective container: cracked/broken cartridges
Is a recalled 3% Polocaine DENTAL dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of 3% Polocaine DENTAL are affected?
Distributed: U.S.A. Nationwide. The recall covers these lots — Lot: D05159C, expires: 07-31-2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0230-2026.

Source: openFDA Drug Enforcement record D-0230-2026

← All drug recalls